Omega Healthcare Investors, Inc. $OHI Shares Sold by Amundi

Amundi reduced its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 71.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 576,669 shares of the real estate investment trust's stock after selling 1,462,578 shares during the quarter. Amundi owned about 0.20% of Omega Healthcare Investors worth $22,288,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. NBC Securities Inc. bought a new stake in Omega Healthcare Investors during the first quarter worth approximately $29,000. CoreCap Advisors LLC grew its stake in shares of Omega Healthcare Investors by 177.3% during the fourth quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock valued at $60,000 after buying an additional 1,009 shares during the last quarter. Park Square Financial Group LLC bought a new position in shares of Omega Healthcare Investors during the fourth quarter valued at approximately $61,000. UMB Bank n.a. grew its stake in shares of Omega Healthcare Investors by 94.9% during the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after buying an additional 1,059 shares during the last quarter. Finally, Meeder Asset Management Inc. grew its stake in shares of Omega Healthcare Investors by 1,581.3% during the first quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust's stock valued at $96,000 after buying an additional 2,372 shares during the last quarter. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Trading Down 0.0%

Shares of NYSE OHI traded down $0.01 during trading hours on Friday, reaching $42.49. The stock had a trading volume of 1,550,013 shares, compared to its average volume of 1,686,146. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a market cap of $12.53 billion, a price-to-earnings ratio of 26.23, a P/E/G ratio of 2.23 and a beta of 0.71. The business's fifty day moving average price is $40.26 and its two-hundred day moving average price is $38.23. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $44.42.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million during the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.Omega Healthcare Investors's quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.3%. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Truist Financial upped their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Wells Fargo & Company upped their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Raymond James Financial reaffirmed an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Mizuho upped their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research note on Thursday. Finally, Royal Bank Of Canada upped their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat.com, Omega Healthcare Investors has an average rating of "Moderate Buy" and an average price target of $43.75.

Insiders Place Their Bets

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.50% of the stock is currently owned by corporate insiders.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.